Premium
Toxicology and carcinogenicity studies of diuretics in F344 rats and B6C3F1 mice 2. Furosemide
Author(s) -
Bucher John R.,
Huff James,
Haseman Joseph K.,
Eustis Scot L.,
Davis William E.,
Meierhenry Earl F.
Publication year - 1990
Publication title -
journal of applied toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.784
H-Index - 87
eISSN - 1099-1263
pISSN - 0260-437X
DOI - 10.1002/jat.2550100510
Subject(s) - furosemide , endocrinology , medicine , diuretic , toxicity , carcinogen , nephrosis , kidney , physiology , biology , genetics
Abstract Toxicology and carcinogenesis studies of furosemide, a widely used diuretic, were conducted by administering diets containing the drug to both sexes of F344 rats and B6C3F1 mice in 14‐day, 13‐week and 2‐year studies. Deaths occurred among rats and mice receiving diets containing 46 000 ppm furosemide in 14‐day studies, and animals given diets containing lower concentrations lost weight. No deaths were seen in 13‐week studies using top concentrations ranging from 10 000 to 20 000 ppm, but animals at higher concentrations had lower weight gains than controls. Nephrosis in rats and mice was the only significant compound‐related lesion observed in the prechronic studies. In 2‐year studies, rats received diets containing 0, 350 or 700 ppm furosemide and mice received diets containing 0, 700 or 1400 ppm furosemide. Survival of dosed and control rats of both sexes and male mice was similar; survival of high‐dose female mice was lower than controls. Nephropathy was increased in male rats and in male and female mice. In female mice, increased malignant tumors of the mammary gland were associated with furosemide administration. In male rats, marginal increases in tubular cell neoplasms of the kidney and in meningiomas of the brain were observed in dosed animals, but these were not considered to be related clearly to exposure to furosemide.